secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2025-12-19T23:59:59+00:00
Accession:  0001104659-25-123211
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Profound Medical prices $36M registered direct offering and up to $4M private placement at $7.00/share
--------------------------------------------------------------------------------

- Sold 5,142,870 common shares at $7.00 each in registered direct offering; gross proceeds ~$36M.
- Planned private placement in Canada of up to 571,428 common shares at $7.00 for up to $4M additional proceeds.
- Both tranches have no warrant coverage; placement agent is Konik Capital Partners (5% cash fee).
- Registered direct closing expected Dec 22, 2025; private placement closing on or before Dec 30, 2025.
- Net proceeds for sales/marketing expansion, working capital, R&D, and strategic transactions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000110465925123211/0001104659-25-123211-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000110465925123211/tm2533900d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-123211

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer